CC
ARKG icon

Corsicana & Co’s ARK Genomic Revolution ETF ARKG Stock Holding History

Corsicana & Co’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-330
Closed -$20K – 214
2021
Q4 		$20K Hold
330
– – 0.01% 167
2021
Q3 		$25K Hold
330
– – 0.02% 157
2021
Q2 		$31K Buy
+330
New +$28.1K 0.02% 145

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Corsicana & Co's ARKG Position: Q1 2022 in Review

Corsicana & Co sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 330 shares — an estimated $20K sold.

Corsicana & Co first reported a position in ARKG in Q2 2021 and held it in 3 quarters. The position peaked at $31K in Q2 2021. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Corsicana & Co reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
  • Corsicana & Co sold 330 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $20K.
  • Corsicana & Co first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 3 quarters.
  • Corsicana & Co's ARK Genomic Revolution ETF position peaked at $31K in Q2 2021.
  • 387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Corsicana & Co's 13F filing for Q1 2022, filed 8 Apr 2022.